MARY HEAROD: Open Payments
NPI 1144760414 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,118 in 157 payments from 17 companies in 2025. Trend: 2023 $1,793 · 2024 $2,064 · 2025 $2,118
Food & beverage: $2,014Education: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $542 |
| Janssen Biotech, Inc. | 21 | $432 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $175 |
| Ardelyx, Inc. | 8 | $149 |
| Gilead Sciences, Inc. | 6 | $138 |
| PFIZER INC. | 7 | $117 |
| Madrigal Pharmaceuticals | 5 | $79 |
| QOL Medical, LLC | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 10 | $52 |
Products named: TREMFYA, RINVOQ, CREON, IBSRELA, ENTYVIO, XIFAXAN, SKYRIZI, REZDIFFRA.
Industry payments across LA — which companies pay providers there.
